A Study of the Treatment of Postmenopausal Women With Osteoporosis

Osteoporosis, Post-Menopausal Clinical Trial

Official title:
Comparison of Teriparatide and Calcitonin in the Treatment of Postmenopausal Women With Osteoporosis

Status Completed

Clinical Trial Summary

To compare the effect of treatment with teriparatide with that of salmon calcitonin in postmenopausal women with osteoporosis.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00543023
Study type	Interventional
Source	Eli Lilly and Company
Contact
Status	Completed
Phase	Phase 3
Start date	June 2003
Completion date	August 2004

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00532207` - Study of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis	Phase 3
Completed	`NCT00018447` - Combination Osteogenic Therapy in Established Osteoporosis	Phase 2
Completed	`NCT00532246` - Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Placebo	Phase 4
Completed	`NCT00927186` - Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women	Phase 4
Completed	`NCT00543218` - PTH Comparison in Post Menopausal Women	Phase 3
Completed	`NCT00532428` - Long Term Effects of Raloxifene Treatment on Bone Quality	Phase 4
Completed	`NCT00532545` - Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis	Phase 4